Expression of a soluble transforming growth factor-beta (TGFbeta) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo.

Author List
Witham TF, Villa L, Yang T, Pollack IF, Okada H, Robbins PD, Chambers WH
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1433785
Publication Year
2003
PubMed ID
12952287
Publication Title
Witham TF, Villa L, Yang T, Pollack IF, Okada H, Robbins PD, Chambers WH. Expression of a soluble transforming growth factor-beta (TGFbeta) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo. J Neurooncol. 2003 Aug-Sep; 64(1-2):63-9.